FXYD5 and neoplasm: Furthermore, immunofluorescence (IF) analysis revealed that compared with control (ApcMin/+) mice, dysadherin-KO (Fxyd5−/−) mice presented lower CA9 expression in primary tumor lesions (Fig. 3g, Supplementary Fig. 4m).